Article
Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.
Transplantation - 27 Apr 2013
Gracia-Ahufinger Irene, Gutiérrez-Aroca Juan, Cordero Elisa, Vidal Elisa, Cantisán Sara, del Castillo Domingo, Martín-Gandul Cecilia, Rivero Antonio, Torre-Cisneros Julián
Abstract excerpt
BACKGROUND: Experience with high-dose ganciclovir for the management of resistant cytomegalovirus (CMV) replication in transplant patients is limited despite its adoption as an effective therapy by some consensus documents. METHODS: We studied six cases of CMV replication in solid organ transplant patients whose genotypic testing showed mutations associated with different levels of resistance to ganciclovir. All...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
